Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC): Longterm outcomes from JAVELIN Bladder 100 in subgroups defined by response to 1L chemotherapy.
- Authors
- Perez-Valderrama, B[Perez-Valderrama, Begona]; Powles, T[Powles, Thomas]; Sridhar, SS[Sridhar, Srikala S.]; Caserta, C[Caserta, Claudia]; Loriot, Y[Loriot, Yohann]; Gupta, S[Gupta, Shilpa]; Bellmunt, J[Bellmunt, Joaquim]; Sternberg, CN[Sternberg, Cora N.]; Wang, J[Wang, Jing]; Costa, N[Costa, Nuno]; Laliberte, RJ[Laliberte, Robert J.]; Di Pietro, A[Di Pietro, Alessandra]; Park, SH[Park, Se Hoon]; Grivas, P[Grivas, Petros]
- Issue Date
- 1-Jun-2022
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.40, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 40
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.